If a medication is to be delivered to one very specific, hard-to-reach spot, without damaging other parts of the body, a robot would have to get the job done:
Bionaut's initial trials will target brain tumors and the rare pediatric neurological disorder Dandy-Walker Syndrome, which causes large cysts to form on the cerebellum. The goal is to one day treat much more complex but common issues like Parkinson's, Hungtington's, Alzheimer's, and strokes.
The FDA has already granted approvals to help accelerate the clinical trials, and previously skeptical medical experts are seeing the potential.
Комментарии